Question · asked by 1 review

Summary of findings: pioglitazone monotherapy vs intensive behaviour‐changing intervention: Health‐related quality of life

Population
people at increased risk for developing type 2 diabetes
Intervention
Summary of findings: pioglitazone monotherapy
Comparison
intensive behaviour‐changing intervention
Outcome
Health‐related quality of life

The review found no eligible studies for this question.

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Summary of findings: pioglitazone monotherapy vs intensive behaviour‐changing intervention
Health‐related quality of life · people at increased risk for developing T2DM
The review found no eligible studies for this question.
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people… (2020) · Cochrane Headline outcomes only
no estimate extractedNot reportedNo studies found

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of…
2020 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.